|
Andrew Aromando has over 13 years of experience in the pharmaceutical industry, holding positions of increasing responsibility in business development, strategic planning, management consulting, market research, marketing and sales. Prior to joining Alfacell, he was a senior executive at Innovex, a division of Quintiles Transnational Corporation, from 2000 to 2004. From 2002 to 2004, Mr. Aromando served as Vice President, Business Development, North America, where he led the development and execution of commercial strategies and tactics for branded pharmaceutical products across many therapeutic areas, including oncology. He also successfully managed significant strategic partnerships with several major, mid-size and emerging pharmaceutical, biotechnology and medical device companies. Prior to Innovex, Mr. Aromando held senior management positions at Strategic Business Research (1998 to 2000) and LARK Marketing Support Services (1994 to 1998), two leading pharmaceutical industry service suppliers. He began his career in the industry in 1992 as a sales representative with Sandoz Pharmaceuticals. Mr. Aromando holds a B.A. from The College of New Jersey and a M.A. from Rutgers University.
| 